Toll-like receptor 7 agonist imiquimod (R837) was effectively loaded into mesoporous dopamine (MPDA) NPs by Wang et al. Effective DC activation and a CD8+ T-cell response were observed, which can be used for the combination of photothermal therapy and immunotherapy, particularly in the treatment of melanoma. The gene discussed is CD8A; the disease is melanoma.